Advent Life Sciences announces sale of KaNDy Therapeutics to Bayer
The sale is for $425 million upfront plus potential milestone payments of up to $425 million followed by further potential…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.